TFAM and cardiac hypertrophy: A recent cell culture study demonstrated that miR-4458 negatively modulated cardiac hypertrophy, a known intermediate phenotype, and an independent risk factor for ischemic stroke, by activating mitochondrial transcription factor A (TFAM), a well-recognized myocardial protective protein.